References

AAAI (American Academy of Allergy and Immunology). 1986. Clinical ecology. Executive Committee of the American Academy of Allergy and Immunology. J. Allergy Clin. Immunol. 78(2):269–271.

AAAAI (American Academy of Allergy Asthma and Immunology). 1999. Physician Reference Materials: Position Statement 35: Idiopathic Environmental Tolerances. AAAAI Board of Directors. JACI 103:36–40. [Online]. Available: http://www.aaaai.org/professional/physicianreference/positionstatements/ps35.stm. [March 15, 1999].

Alder, H.L., and E.B.Roessler. 1968. P. 191 in Introduction to Probability and Statistics, 4th Ed. San Francisco: W.H.Freeman.

Aleksieva, Z. 1983. Sulphur compounds. Pp. 2122–2124 in Encyclopedia of Occupational Health and Safety, L.Prameggiani, ed. Geneva: International Labour Office.

Allen, B.C., R.J.Kavlock, C.A.Kimmel, and E.M.Faustman. 1994. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487–495.

Ashford, N. 1999. Low-level chemical sensitivity: Implications for research and social policy. Toxicol. Ind. Health 15(3–4):421–427.

Ashford, N., and C.Miller. 1998. Chemical Exposures: Low Levels and High Stakes, 2nd Ed. New York: John Wiley & Sons.


Balmes, J.R., J.M.Fine, and D.Sheppard. 1987. Symptomatic bronchoconstriction after short-term inhalation of sulfur dioxide. Am. Rev. Respir. Dis. 136(5):1117–1121.

Barnes, D.G., and M.L.Dourson. 1988. Reference dose (RfD): Description and use in health risk assessments. Regul. Toxicol. Pharmacol. 8(4):471–486.

Barnes, G.B., G.P.Daston, J.S.Evans, A.M.Jarabek, R.J.Kavlock, C.A.Kimmel, C.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals References AAAI (American Academy of Allergy and Immunology). 1986. Clinical ecology. Executive Committee of the American Academy of Allergy and Immunology. J. Allergy Clin. Immunol. 78(2):269–271. AAAAI (American Academy of Allergy Asthma and Immunology). 1999. Physician Reference Materials: Position Statement 35: Idiopathic Environmental Tolerances. AAAAI Board of Directors. JACI 103:36–40. [Online]. Available: http://www.aaaai.org/professional/physicianreference/positionstatements/ps35.stm. [March 15, 1999]. Alder, H.L., and E.B.Roessler. 1968. P. 191 in Introduction to Probability and Statistics, 4th Ed. San Francisco: W.H.Freeman. Aleksieva, Z. 1983. Sulphur compounds. Pp. 2122–2124 in Encyclopedia of Occupational Health and Safety, L.Prameggiani, ed. Geneva: International Labour Office. Allen, B.C., R.J.Kavlock, C.A.Kimmel, and E.M.Faustman. 1994. Dose-response assessment for developmental toxicity. II. Comparison of generic benchmark dose estimates with no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):487–495. Ashford, N. 1999. Low-level chemical sensitivity: Implications for research and social policy. Toxicol. Ind. Health 15(3–4):421–427. Ashford, N., and C.Miller. 1998. Chemical Exposures: Low Levels and High Stakes, 2nd Ed. New York: John Wiley & Sons. Balmes, J.R., J.M.Fine, and D.Sheppard. 1987. Symptomatic bronchoconstriction after short-term inhalation of sulfur dioxide. Am. Rev. Respir. Dis. 136(5):1117–1121. Barnes, D.G., and M.L.Dourson. 1988. Reference dose (RfD): Description and use in health risk assessments. Regul. Toxicol. Pharmacol. 8(4):471–486. Barnes, G.B., G.P.Daston, J.S.Evans, A.M.Jarabek, R.J.Kavlock, C.A.Kimmel, C.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Park, and H.L.Spitzer. 1995. Benchmark dose workshop: Criteria for use of a benchmark dose to estimate a reference dose. Regul. Toxicol. Pharmacol. 21(2):296–306. Barnes, J.M., and F.A.Denz. 1954. Experimental methods used in determining chronic toxicity. Pharmacol. Rev. 6:191–242. Bigwood, E.J. 1973. The acceptable daily intake of food additives. CRC Crit. Rev. Toxicol. 2(1):41–93. Bliss, C.I. 1935a. The calculation of the dosage-mortality curve. Ann. Appl. Bio. 22:134–167. Bliss, C.I. 1935b. The comparison of the dosage-mortality data. Ann. Appl. Bio. 22:307–333. Bogdanffy, M.S., R.Sarangapani, D.R.Plowchalk, A.Jarabek, and M.E.Andersen. 1999. A biologically based risk assessment for vinyl acetate-induced cancer and noncancer inhalation toxicity. Toxicol. Sci. 51(1):19–35. Bogen, K.T. 1989. Cell proliferation kinetic and multistage cancer risk models. J. Natl. Cancer Inst. 81(4):267–277. Brown, N.A., and S.Fabro. 1983. The value of animal teratogenicity testing for predicting human risk. Clin. Obst. Gynecol. 26(2):467–477. Brown-DeGagne, A.M., and J.McGlone. 1999. Multiple chemical sensitivity: A test of the olfactory-limbic model. J. Occup. Environ. Med. 41(5):366–377. Bruckner, J.V., and W.B.Weil. 1999. Biological factors which may influence an older child’s or adolescent’s responses to toxic chemicals. Regul. Toxicol. Pharmacol. 29(2 Pt 1):158–164. Calabrese, E.J. 1983. Principles of Animal Extrapolation. Reprinted 1991. New York: Wiley. Calabrese, E.J. 1985. Uncertainty factors and interindividual variation. Regul. Toxicol. Pharmacol. 5:190–196. Chan, M.T., P.Mainland, and T.Gin. 1996. Minimum alveolar concentration of halothane and enflurane are decreased in early pregnancy. Anesthesiology 85(4):782–786. Chen, J.J., R.L.Kodell, and D.W.Gaylor. 1988. Using the biological two-stage model to assess risk from short-term exposures. Risk Anal. 8(2):223–230. Crump, K.S., and R.B.Howe. 1984. The multistage model with a time-dependent dose pattern: Applications to carcinogenic risk assessment. Risk Anal. 4:163–176. Cullen, M.R. 1987. The worker with multiple chemical sensitivities: An overview. Occup. Med. 2(4):655–661. Done, A.K. 1964. Developmental pharmacology. Clin. Pharmacol. Ther. 5:432–479. (as cited in NRC, 1993b). Dourson, M. 1996. Uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 24(2):107. Dourson, M.L., and J.F.Stara. 1983. Regulatory history and experimental support of uncertainty (safety) factors. Regul. Toxicol. Pharmacol. 3(3):224–238. Dourson, M.L., S.P.Felter, and D.Robinson. 1996. Evolution of science-based uncertainty factors in noncancer risk assessment. Regul. Toxicol. Pharmacol. 24(2):108–120.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Dourson, M.L., L.A.Knauf, and J.C.Swartout. 1992. On reference dose (RfD) and its underlying toxicity data base. Toxicol. Ind. Health 8(3):171–189. ECETOC (European Chemical Industry Ecology and Toxicology Centre). 1991. Pp. 28–29 in Emergency Exposure Indices for Industrial Chemicals. Tech. Report no. 43. Brussels, Belgium: European Chemical Industry Ecology and Toxicology Centre. EPA (U.S. Environmental Protection Agency). 1980. Guidelines and Methodology Used in the Preparation of Health Assessment Chapters of the Consent Decree Water Quality Criteria. Fed. Regist. 45:79347–79357. EPA (U.S. Environmental Protection Agency). 1986. Guidelines for Carcinogen Risk Assessment. Fed. Regist. 51(185):33992–34003. EPA (U.S. Environmental Protection Agency). 1987. Technical Guidance for Hazards Analysis. Emergency Planning for Extremely Hazardous Substances. U.S. Environmental Protection Agency, Federal Emergency Management Agency, U.S. Department of Transportation, Washington, DC. EPA (U.S. Environmental Protection Agency). 1991. National Primary Drinking Water Regulations, Final rule. 40 CFR Parts 141, 142, and 143. Fed. Regist. 56(20):3526–3597. January 30. EPA (U.S. Environmental Protection Agency). 1992. Draft report: A Cross-Species Scaling Factor for Carcinogen Risk Assessment Based on Equivalence of mg/kg3/4/day. Fed. Regist. 57(109):24152–24173. EPA (U.S. Environmental Protection Agency). 1993. Styrene. The Integrated Risk Information System (IRIS). National Center for Environmental Assessment, Washington, D.C. Available: http://www.epa.gov/ngispgm3/iris/subst/0104.htm [1/3/01, last updated 5/5/98]. EPA (U.S. Environmental Protection Agency). 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8–90/066F. Environmental Criteria and Assessment Office, Office of Research and Development, U.S. Environmental Protection Agency, Research Triangle Park, NC. October. EPA (U.S. Environmental Protection Agency). 1995a. The Use of the Benchmark Dose Approach in Health Risk Assessment. EPA/630/R-94/007. Risk Assessment Forum. U.S. Environmental Protection Agency, Washington, DC. February. EPA (U.S. Environmental Protection Agency). 1995b. Methylmercury. The Integrated Risk Information System (IRIS). National Center for Environmental Assessment, Washington, D.C. Available: http://www.epa.gov/ngispgm3/iris/subst/0073.htm/. [1/3/01, last updated 5/5/98]. EPA (U.S. Environmental Protection Agency). 1996a. Proposed Guidelines for Carcinogen Risk Assessment. EPA/600/P-92/003C. Office of Research and Development, U.S. Environmental Protection Agency, Washington, DC. April. EPA (U.S. Environmental Protection Agency). 1996b. Aroclor 1016. The Integrated Risk Information System (IRIS). National Center for Environmental Assessment, Washington, D.C. Available: http://www.epa.gov/iris/. EPA (U.S. Environmental Protection Agency). 1999. Health Effects Test Guidelines. Code of Federal Regulations 40: Part 798. Available: http://www.epa.gov/docs/OPPTS_Harmonized/.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals EPA (U.S. Environmental Protection Agency). 2000. Benchmark Dose Software Draft Beta Version 1.2., National Center for Environmental Assessment, Office of Research and Development. [Online]. Available: http://www.epa.gov/ncea/bmds.htm. [1/3/01, last updated 1/2/01]. Evans, R.D., R.S.Harris, and J.W.M.Bunker. 1944. Radium metabolism in rats, and the production of osteogenic sarcoma by experimental radium poisoning. Am. J. Roentgenol. 52:353–373. Faustman, E.M., B.C.Allen, R.J.Kavlick, and C.A.Kimmel. 1994. Dose-response assessment for developmental toxicity. I. Characterization of database and determination of no observed adverse effect levels. Fundam. Appl. Toxicol. 23(4):478–486. FDA (U.S. Food and Drug Administration). 1985. Sponsored compounds in food-producing animals. Proposed Rule and Notice. Fed. Regist. 50:45530–45556. Finney, D.J. 1971. Probit Analysis, 3rd Ed. London: Cambridge University Press. Flury, F. 1921. Über Kampfgasvergiftungen. I. Über Reizgase. Z. Ges. Exp. Med. 13:1. Food Safety Council. 1982. A Proposed Food Safety Evaluation Process. The Nutrition Foundation, Inc., Washington, DC. Fowles, J.R., G.V.Alexeeff, and D.Dodge. 1999. The use of benchmark dose methodology with acute inhalation lethality data. Regul. Toxicol. Pharmacol. 29(3):262–278. Frank, R. 1980. SO2-particulate interactions: recent observations. Am. J. Ind. Med. 1(3–4):427–434. Frederick, C.B., M.L.Bush, L.G.Lomax, K.A.Black, L.Finch, J.S.Kimbell, K.T. Morgan, R.P.Subramaniam, J.B.Morris, and J.S.Ultman. 1998. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways. Toxicol. Appl. Pharmacol. 152(1):211–231. Gaylor, D.W. 1996. Quantalization of continuous data for benchmark dose estimation. Regul. Toxicol. Pharmacol. 24(3):246–250. Gaylor, D.W., R.L.Kodell, J.J.Chen, and D.Krewski. 1999. A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors. Regul. Toxicol. Pharmacol. 29(2 Pt 1):151–157. Gaylor, D.W., L.Ryan, D.Krewski, and Y.Zhu. 1998. Procedures for calculating benchmark doses for health risk assessment. Regul. Toxicol. Pharmacol. 28(2):150–164. Glaubiger, D.L., D.D.von Hoff, J.S.Holcenbern, B.Kamen, C.Pratt, and R.S. Ungerleider. 1982. The relative tolerance of children and adults to anticancer drugs. Front. Radiat. Ther. Oncol. 16:42–49. Goddard, M.J., M.J.Murdoch, and D.Krewski. 1995. Temporal aspects of risk characterization. Inhalation Toxicol. 7(6):1005–1018. Goldenthal, E.I. 1971. A compilation of LD50 values in newborn and adult animals. Toxicol. Appl. Pharmacol. 18(1):185–207. Graveling, R.A., A.Pilkington, J.P.George, M.P.Butler, and S.N.Tannahill. 1999. A review of multiple chemical sensitivity. Occup. Environ. Med. 56(2):73–85.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Gregory, G.A., E.I.Eger 2nd, and E.S.Munson. 1969. The relationship between age and halothane requirements in man. Anesthesiology 30(5):488–491. Guth, D.J., A.M.Jarabek, L.Wymer, and R.C.Hertzberg. 1991. Evaluation of Risk Assessment Methods for Short-Term Inhalation Exposure. Paper No. 91–173.2. Paper presented at the 84th Annual Meeting of the Air and Waste Management Association, June 16–21, 1991, Vancouver, BC. Haber, F. 1924. Zur Geschichte des Gaskrieges. Pp. 76–92 in Fünf Vorträge aus den Jahren 1920–1923. Berlin: Springer-Verlag. Hattis, D., and E.Anderson. 1999. What should be the implications of uncertainty, variability, and inherent “biases”/“conservatism” for risk management decision-making? Risk Anal. 19(1):95–107. Hattis, D., and K.Barlow.. 1996. Human interindividual variability in cancer risks-technical and management challenges. Human Ecol. Risk Assesses. 2(1):194–220 . Hattis, D., and D.E.Burmaster. 1994. Assessment of variability and uncertainty distributions for practical risk analyses. Risk Anal. 14(5):713–730. Hattis, D., P.Banati, and R.Goble 1999. Distributions of individual susceptibility among humans for toxic effects—For what fraction of which kinds of chemicals and effects does the traditional 10-fold factor provide how much protection? Ann. N.Y. Acad. Sci. 895:286–316. Hattis, D., L.Erdreich, and M.Ballew. 1987. Human variability in susceptibility to toxic chemicals: A preliminary analysis of pharmacokinetic data from normal volunteers. Risk Anal. 7(4):415–426. Hayes, W.J. 1967. Toxicity of pesticides to man: Risks from present levels. Proc. R. Soc. Lond. B. Biol. Sci. 167(7):101–127. Henderson, R. 1992. Short-term exposure guidelines for emergency response: The approach of the Committee on Toxicology. Pp. 89–92 in Conference on Chemical Risk Assessment in the Department of Defense (DOD): Science Policy and Practice, H.J.Clewell, ed. Cincinnati, OH: American Conference of Governmental Industrial Hygienists. Hertzberg, R.C., and M.Miller. 1988. A statistical model for species extrapolation using categorical response data. Toxicol. Ind. Health 1(4):43–57. Hertzberg, R.C., and L.Wymer. 1991. Modeling the severity of toxic effects. Paper no. 91–173.4. Paper presented at the 84th Annual Meeting of the Air and Waste Management Association, June 16–21, 1991, Vancouver, BC. Horstman, D.H., E.Seal, L.J.Folinsbee, P.Ives, and J.Roger. 1988. The relationship between exposure duration and sulfur dioxide-induced bronchoconstriction in asthmatic subjects. Am. Ind. Hyg. Assoc. J. 49:38–47. Howe, R.B., K.S.Crump, and C.Van Landingham. 1986. GLOBAL86: A Computer Program to Extrapolate Quantal Animal Toxicity Data to Low Doses. Subcontract No. 2–251U-2745. Prepared for U.S. Environmental Protection Agency, Washington, DC. Interagency Workgroup on Multiple Chemical Sensitivity. 1998. A Report on Multiple Chemical Sensitivity (MCS). A predecisional draft. The Environmental Health Policy Committee. [Online]. Available: http://web.health.gov/environment/mcs/toc.htm. [August 24, 1998].

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals IPCS (International Programme on Chemical Safety). 1994. Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health-Based Exposure Limits. Environmental Health Criteria No. 170. Geneva: World Health Organization. IPCS (International Programme on Chemical Safety). 1996. Report of Multiple Chemical Sensitivities Workshop. February 21–23, 1996. Berlin, Germany. Jarabek, A.M., M.G.Menache, J.H.Overton, M.L.Dourson, and F.J.Miller. 1990. The U.S. Environmental Protection Agency’s inhalation RfD methodology: Risk assessment for air toxics. Toxicol. Ind. Health 6(5):279–302. Katoh, T., and K.Ikeda. 1992. Minimum alveolar concentration of sevoflurane in children. Br. J. Anaesth. 68(2):139–141. Kepler, G.M., R.B.Richardson, K.T.Morgan, and J.S.Kimbell. 1998. Computer simulation of inspiratory nasal airflow and inhaled gas uptake in a rhesus monkey. Toxicol. Appl. Pharmacol. 150(1):1–11. Keplinger, M.L., and L.W.Suissa. 1968. Toxicity of fluorine short-term inhalation. Am. Ind. Hyg. Assoc. J. 29(1):10–18. Kimbell, J.S., E.A. Gross, D.R. Joyner, M.N. Godo, and K.T. Morgan. 1993. Application of computational fluid dynamics to regional dosimetry of inhaled chemicals in the upper respiratory tract of the rat. Toxicol. Appl. Pharmacol. 121(2):253–263. Kimbell, J.S., E.A.Gross, R.B.Richardson, R.B.Conolly, and K.T.Morgan. 1997a. Correlation of regional formaldehyde flux predictions with the distribution of formaldehyde-induced squamous metaplasia in F344 rat nasal passages. Mutat. Res. 380(1–2):143–154. Kimbell, J.S., M.N.Godo, E.A.Gross, D.R.Joyner, R.B.Richardson, and K.T.Morgan. 1997b. Computer simulation of inspiratory airflow in all regions of the F344 rat nasal passages. Toxicol. Appl. Pharmacol. 145(2):388–398. Kipen, H.M., and N.Fiedler. 1999. Invited commentary: Sensitivities to chemicals-context and implications. Am. J. Epidemiol. 150(1):13–16. Klaassen, C.D., and J.Doull. 1980. Evaluation of safety: Toxicological evaluation. Pp. 26 in Cassarett and Doull’s Toxicology, The Basic Science of Poisons, J.Doull, C.D.Klaassen, and M.O.Amdur, eds. New York.: Macmillan. Kodell, R.L., D.W.Gaylor, and J.J.Chen. 1987. Using average lifetime dose rate for intermittent exposures to carcinogens. Risk Anal 7(3):339–345. Koenig, J.Q., W.E.Pierson, M.Horike, and R.Frank. 1981. Effects of SO2 plus NaCl aerosol combined with moderate exercise on pulmonary function in asthmatic adolescents. Environ. Res. 25(2):340–348. Koenig, J.Q., W.E. Pierson, M. Horike, and R. Frank. 1982. Effects of inhaled sulfur dioxide (SO2) on pulmonary function in healthy adolescents: Exposure to SO2+ sodium chloride droplet aerosol during rest and exercise. Arch. Environ. Health. 37(1):5–9. Koenig, J.Q., K.Dumler, V.Rebolledo, P.V.Williams, and W.E.Pierson. 1993. Respiratory effects of inhaled sulfuric acid on senior asthmatics and nonasthmatics. Arch. Environ. Health 48(3):171–175. Kokoski, C.J. 1976. Written testimony of Charles J.Kokoski, Docket No. 76N-0070. Food and Drug Administration, Washington, DC.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Kreutzer, R., R.R.Neutra, and N.Lashuay. 1999. Prevalence of people reporting sensitivities to chemicals in a population-based survey. Am. J. Epidemiol. 150(1):1-12. LeDez, K.M., and J.Lerman. 1987. The minimum alveolar concentration (MAC) of isoflurane in preterm neonates. Anesthesiology 67(3):301–307. Lehman, A.J., and O.G.Fitzhugh. 1954. 100-fold margin of safety. Assoc. Food Drug Off. U.S.Q. Bull. 18:33–35. Leisenring, W. and L.Ryan. 1992. Statistical properties of the NOAEL. Regul. Toxicol. Pharmacol. 15(2 Pt 1):161–171. Lerman, J., S.Robinson, M.M.Willis, and G.A.Gregory. 1983. Anesthetic requirements for halothane in young children 0–1 month and 1–6 months of age. Anesthesiology 59(5):421–424. Linn, W.S., E.L.Avol, R.C.Peng, D.A.Shamoo, and J.D.Hackney. 1987. Replicated dose-response study of sulfur dioxide effects in normal, atopic, and asthmatic volunteers. Am. Rev. Respir. Dis. 136(5):1127–1134. Litchfield Jr., J.T., and F.Wilcoxon. 1948. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:99–113. Lu, F.C. 1979. Assessments at an international level of health hazards to man of chemicals shown to be carcinogenic in laboratory animals. Pp. 315–328 in Regulatory Aspects of Carcinogenesis, F.Coulston, ed. New York: Academic Press. Lu, F.C. 1988. Acceptable daily intake: Inception, evolution, and application. Regul. Toxicol. Pharmacol. 8(1):45–60. Lu, F.C., and R.L.Sielken, Jr. 1991. Assessment of safety/risk of chemicals: Inception and evolution of the ADI and dose-response modeling procedures. Toxicol. Lett. 59(1–3):5–40. Marsoni, S., R.S.Ungerleider, S.B.Hurson, R.M.Simon, and L.D.Hammershaimb. 1985. Tolerance to antineoplastic agents in children and adults. Cancer Treat. Rep. 69(11):1263–1269. McLellan, R.K., C.E.Becker, J.B.Borak, C.Coplein, A.M.Ducatman, E.A.Favata, J.F.Green, J.Herzstein, A.T.Jolly, J.Kalnas, K.Kulig, H.M.Kipen, D.C.Logan, F.L.Mitchell, H.W.McKinnon, M.A.Roberts, M.Russi, H.J.Sawyer, M.J. Sepulveda, M.J.Upfal, and M.C.Zepeda. 1999. ACOEM Position statement. Multiple chemical sensitivities: Idiopathic environmental intolerance. J. Occup. Environ. Med. 41(11):940–942. Meek, M.E., R.Newhook, R.G.Liteplo, and V.C.Armstrong. 1994. Approach to assessment of risk to human health for priority substances under the Canadian Environmental Protection Act. Environ. Carcinogen. Ecotoxicol. Rev. 12(2):105–134. Mitchell, F.L. 1995. Multiple Chemical Sensitivity: A Scientific Overview. Princeton, N.J.: Princeton Scientific. Moolgavkar, S.H., and G.Luebeck. 1990. Two-event model for carcinogenesis: Biological, mathematical, and statistical considerations. Risk Anal. 10(2):323–341. Morrison, P.F. 1987. Effects of time-variant exposure on toxic substance response. Environ. Health Perspect. 76:133–140. Murdoch, D.J., and D.Krewski. 1988. Carcinogenic risk assessment with time-dependent exposure patterns. Risk Anal. 8(4):521–530.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Murdoch, D.J., D.Krewski, and J.Wargo. 1992. Cancer risk assessment with intermittent exposure. Risk Anal. 12(4):569–577. NRC (National Research Council). 1977. Drinking Water and Health. Washington, DC : National Academy Press. NRC (National Research Council). 1983. Risk Assessment in the Federal Government. Washington, DC: National Academy Press. NRC (National Research Council). 1985. Emergency and Continuous Exposure Guidance Levels for Selected Airborne Contaminants, Vol. 5. Washington, DC: National Academy Press. NRC (National Research Council). 1986. Criteria and Methods for Preparing Emergency Exposure Guidance Level (EEGL), Short-Term Public Emergency Guidance Level (SPEGL), and Continuous Exposure Guidance Level (CEGL) Documents. Appendix F Washington, DC: National Academy Press. NRC (National Research Council). 1992a. Guidelines for Developing Spacecraft Maximum Allowable Concentrations for Space Station Contaminants. Washington, DC: National Academy Press. NRC (National Research Council). 1992b. Multiple Chemical Sensitivities: A Workshop. Washington, DC: National Academy Press. NRC (National Research Council). 1992c. Biologic Markers in Immunotoxicology. Washington, DC: National Academy Press. NRC (National Research Council). 1993a. Guidelines for Developing Community Emergency Exposure Levels for Hazardous Substances. Washington, DC: National Academy Press. NRC (National Research Council). 1993b. Pesticides in the Diets of Infants and Children. Washington, DC: National Academy Press. NRC (National Research Council). 1994. Science and Judgment in Risk Assessment. Washington, DC: National Academy Press. NRC (National Research Council). 2000. Acute Exposure Guideline Levels for Selected Airborne Chemicals, Vol. 1. Washington, DC: National Academy Press. OECD (Organization for Economic Cooperation and Development). 1993. Guidelines for the Testing of Chemicals, ed 1993 11th Addendum, 2000, Paris: OECD. Available: http://www.oecd.org/ehs/test/testlist.htm. PCCRARM (U.S. Presidental/Congressional Commission on Risk Assessment and Risk Management). 1997. Risk Assessment and Risk Management in Regulatory Decision-Making. Final Report, Vol 2. Washington, DC: U.S. Government Printing Office. Pieters, M.N., and H.J.Kramer. 1994. Concentration · Time=Constant? The Validity of Haber’s Law in the Extrapolation of Discontinuous to Continuous Exposition. Rapportnummer 659101 002, National Institute for Public Health and Environmental Protection, The Netherlands. Pohl, H.R., and H.G.Abadin. 1995. Utilizing uncertainty factors in minimal risk levels derivation. Regul. Toxicol. Pharmacol. 22(2):180–188. Renwick, A.G. 1993. Data derived safety factors for the evaluation of food additives and environmental contaminants. Food Addit. Contam. 10(3):275–305. Rhomberg, L.R., and S.K.Wolff. 1998. Empirical scaling of single oral lethal doses across mammalian species based on a large database. Risk Anal. 18(6):741–753.

OCR for page 154
Standing Operating Procedures for Developing Acute Exposure Guideline Levels for Hazardous Chemicals Rinehart, W.E., and T.Hatch. 1964. Concentration-time product (CT) as an expression of dose in sublethal exposures to phosgene. Ind. Hyg. J. 25:545–553. Rondinelli, R.C., J.Q.Koenig, and S.G.Marshall. 1987. The effects of sulfur dioxide on pulmonary function in healthy nonsmoking male subjects aged 55 years and older. Am. Ind. Hyg. Assoc. J. 48(4):299–303. Roger, L.J., H.R.Kehrl, M.Hazucha, and D.H.Horstman. 1985. Bronchoconstriction in asthmatics exposed to sulfur dioxide during repeated exercise. J. Appl. Physiol. 59(3):784–791. Schlesinger, R.B. and I.Jaspers. 1997. Sulfur oxide. Pp 313–330 in Comprehensive Toxicology, Vol. 8. Toxicology of Respiratory System, R.Roth, ed. New York: Pergamon. Schlesinger, R.B. 1999. Nitrogen oxides. Pp. 595–638 in Environmental Toxicants, 2nd. Ed., M.Lippmann, ed. New York; Chichester: Wiley. Sheenan, D.M., and D.W.Gaylor. 1990. Divisions of reproductive & developmental toxicology and biometry. [Abstract]. Teratology 41:590–591. Simon, R.A. 1986. Sulfite sensitivity. Ann. Allergy 56(4):281–288. Spiegel, M.R. 1996. Schaum’s Outline of Theory and Problems of Statistics, 2nd Ed. New York; London: McGraw-Hill. 519 pp. Stevens, W.D., W.M.Dolan, R.T.Gibbons, A.White, E.I.Eger, R.D.Miller, R.H. deJong, and R.M.Elashoff. 1975. Minimum alveolar concentration (MAC) of isoflurande with and without nitrous oxide in patients of various ages. Anesthesiology 42(2):197–200. ten Berge, W.F., A.Zwart, and L.M.Appelman. 1986. Concentration-time mortality response relationship of irritant and systemically acting vapours and gases. J. Hazard. Mater. 13(3):301–309. Truhaut, R. 1991. The concept of the acceptable daily intake: An historical review. Food Addit. Contam. 8(2):151–162. Vettorazzi, G. 1977. Safety factors and their application in the toxicological evaluation. Pp. 207–223 in The Evaluation of Toxicological Data for the Protection of Public Health: Proceedings of the International Colloquium, Luxembourg, December 1976. Oxford: Pergamon. Vettorazzi, G. 1980. Pp. 66–68 in Handbook of International Food Regulatory Toxicology. Vol. 1. Evaluations. New York: SP Medical & Scientific Books. Vocci, F., and T.Farber. 1988. Extrapolation of animal toxicity data to man. Regul. Toxicol. Pharmacol. 8(4):389–398. Weeks, M.H., G.C.Maxey, M.E.Sicks, and E.A.Greene. 1963. Vapor toxicity of UDMH in rats and dogs from short exposures. Am. Ind. Hyg. Assoc. J. 24(2):137–143. Weil, C. 1972. Statistics vs safety factors and scientific judgment in the evaluation of safety for man. Toxicol. Appl. Pharmacol. 21(4):454–463.